Drug Type Small molecule drug |
Synonyms BC-1261, KT 1002 |
Target |
Mechanism FBXO3 inhibitors(F-box protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization ![]() |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 1 | US | Koutif Therapeutics LLCStartup | 05 Nov 2019 |
Crohn Disease | Phase 1 | US | Koutif Therapeutics LLCStartup | 11 Oct 2019 |
Bronchiolitis Obliterans | Preclinical | US | Koutif Therapeutics LLCStartup | 10 Jul 2019 |
Rheumatoid Arthritis | Preclinical | US | Koutif Therapeutics LLCStartup | 12 Aug 2018 |
Acute Lung Injury | Preclinical | US | Koutif Therapeutics LLCStartup | 11 Aug 2018 |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | Koutif Therapeutics LLCStartup | 10 Jul 2018 |